Screening refers to testing to find a disease such as cancer in people who do not have symptoms of that disease. For some types of cancer, screening can help find cancers in an early stage when they are more easily cured. Prostate cancer can often be found early by testing the amount of prostate-specific antigen (PSA) in the blood. Another way to find prostate cancer is the digital rectal exam (DRE), in which your doctor inserts a gloved finger into the rectum to feel the prostate gland. If the results of either one of these tests are abnormal, further testing is needed to see if there is a cancer. If you have routine yearly exams and either one of these test results becomes abnormal, then any cancer you might have has likely been found at an early, more treatable stage. The DRE and the PSA test are both discussed in more detail later in this document.
Since the use of early detection tests for prostate cancer became fairly common (about 1990), the prostate cancer death rate has dropped. But it isn't yet clear if this drop is a direct result of screening or caused by something else, like improvements in treatment.
Unfortunately, there are limits to the current screening methods. Neither the PSA test nor the DRE is 100% accurate. Abnormal results of these tests don't always mean that cancer is present, and normal results don't always mean that there is no cancer. Uncertain or false test results could cause confusion and anxiety. Some men might have a prostate biopsy (which carries its own small risks, along with discomfort) when cancer is not present, while others might get a false sense of security from normal test results when cancer is actually present.
There is no question that the PSA test can help spot many prostate cancers early, but another important issue is that it can't tell how dangerous the cancer is. Finding and treating all prostate cancers early may seem like a no-brainer. But some prostate cancers grow so slowly that they would likely never cause problems. Because of an elevated PSA level, some men may be diagnosed with a prostate cancer that they would have never even known about at all. It would never have caused any symptoms or lead to their death. But they may still be treated with either surgery or radiation, either because the doctor can't be sure how aggressive the cancer might be, or because the men are uncomfortable not having any treatment. These treatments can have side effects that seriously affect a man's quality of life. Doctors and patients are still struggling to decide who should receive treatment and who might be able to be followed without being treated right away (an approach called "watchful waiting" or "expectant management").
source: American Cancer Society
Saturday, September 26, 2009
Subscribe to:
Posts (Atom)